Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Prospective Study to Validate the Imaging Biomarker for NCP (R33)

View source ↗

Summary

Tufts Medical Center updates a prospective study (NCT05653921) to validate an imaging biomarker for neuropathic corneal pain. The trial in patients with dry eye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tufts Medical Center | Conditions: Dry Eye Syndromes, Corneal Disease | Status: SUSPENDED